A high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of four genotoxic impurities in gefitinib

被引:1
作者
Sun Chunyan [1 ,2 ]
Ji Yinghe [1 ]
Qin Kunming [3 ]
Gao Xun [3 ]
Zhao Longshan [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Liaoning, Peoples R China
[2] Yangtze River Pharmaceut Grp Co Ltd, Taizhou 225300, Peoples R China
[3] Jiangsu Ocean Univ, Sch Pharm, Lianyungang 222001, Peoples R China
关键词
high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS); genotoxic; impurity; gefitinib;
D O I
10.3724/SP.J.1123.2019.07002
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In this work, a method for the determination of the amounts of the four genotoxic impurities in gefitinib has been developed. A simple and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLCMS/MS) approach has been developed, optimized, and validated. The genotoxic impurities were 3-chloro-4-fluoroaniline, 3,4-difluoroaniline, 3-fluoro-4-chloroaniline, and 3,4-dichloroaniline-Separation was achieved on an Inertsil ODS-3 column (100 mm x 3.0 mm, 3 mu m). The column temperature was 40 degrees C and the running time was 12 min. A triple quadrupole mass detector with positive electrospray ionization in the multiple reaction monitoring (MRM) mode was applied. The method was validated in terms of its specificity, linearity, precision, accuracy, stability, and robustness. The correlation coefficient of each impurity was higher than 0.999 in the range of 0.6-96.0 mu g/L. The limits of detection (LODs) and limits of quantity (LOQs) were in the ranges of 0.2-2.0 mu g/L and 0.6-6.0 mu g/L, respectively. The recoveries of all impurities at 6, 30, and 60 mu g/L were within 91.0% - 98.5%. All impurities were stable within 2 h. After detection, only 3-chloro-4-fluoroaniline was detected in the batch number 16052301 and R16052501-1 gefitinib samples, but its concentration was below the impurity limit (6 mg/L). This method is simple, reliable, and suitable for the determination of four genotoxic impurities in gefitinib. It can be further applied as a reference for quality control.
引用
收藏
页码:1297 / 1304
页数:8
相关论文
共 23 条
  • [1] [Anonymous], 2014, M7 ASS CONTR DNA REA
  • [2] Bouder Frederic, 2008, Expert Rev Clin Pharmacol, V1, P241, DOI 10.1586/17512433.1.2.241
  • [3] China Food and Drug Administration, 2015, PHARMACOPOEIA PEOPLE
  • [4] EMEA, 2006, CPMPSWP519902 EMEA
  • [5] Highly sensitive HPLC-DAD method for the assay of gefitinib in patient plasma and cerebrospinal fluid: application to a blood-brain barrier penetration study
    Fang, Luo
    Song, Yu
    Weng, Xu
    Li, Fanzhu
    Xu, Yaping
    Lin, Nengming
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2015, 29 (12) : 1937 - 1940
  • [6] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [7] Guan Zhong-Zhen, 2005, Ai Zheng, V24, P980
  • [8] Hou J F, 2018, CHINA MED HERALD, V15, P126
  • [9] Cell Signaling by Receptor Tyrosine Kinases
    Lemmon, Mark A.
    Schlessinger, Joseph
    [J]. CELL, 2010, 141 (07) : 1117 - 1134
  • [10] Li J K, 2017, LIFE SCI INSTRUMENT, V1, P50